The effect of human platelet alloantigen polymorphisms on the in vitro responsiveness to adrenaline and collagen

British Journal of Haematology

Volumn 114, Issue 2, 2001, Pages 387-393

  Theodoropoulos, Ilias ^a   Christopoulos, Costas ^b   Metcalfe, Paul ^c   Dimitriadou, Ekaterini ^d   Economopoulos, Panagiotis ^a   Loucopoulos, Dimitris ^a,e  

^a AMALIA FLEMING GENERAL HOSPITAL   (Greece)

^b NATIONAL INSTITUTE FOR BIOLOGICAL STANDARDS AND CONTROL   (United Kingdom)

^c Amalia Fleming Hospital   (Greece)

^d UNIVERSITY OF ATHENS   (Greece)

^e NONE   (Greece)

Author keywords

Human platelet antigens; Platelet aggregation; Platelet glycoproteins; Platelets; Thrombosis

Indexed keywords

ADRENALIN; ALLOANTIGEN; COLLAGEN; THROMBOCYTE ANTIGEN;

ADULT; ALLELE; ARTICLE; DNA POLYMORPHISM; FEMALE; GENETIC PREDISPOSITION; HUMAN; HUMAN CELL; MALE; NORMAL HUMAN; PREVALENCE; PRIORITY JOURNAL; THROMBOCYTE AGGREGATION; THROMBOGENICITY; THROMBOSIS;

EID: 0034889515     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.2001.02948.x     Document Type: Article

References (46)

1. Role of platelet glycoprotein PL (A1/A2) polymorphism in restenosis after percutaneous transluminal coronary angioplasty
2. Review article: Platelet-collagen interactions: Membrane receptors and intracellular signaling pathways
3. The glycoprotein Ib-IX-V complex in platelet adhesion and signaling
4. 3 subunit (glycoprotein IIIa)
5. Polymorphism of platelet glycoprotein IIb and risk of thrombosis and restenosis after coronary stent placement
6. Platelet-vessel wall interaction: From the bedside to molecules
7. Platelet integrin GPIIb/IIIa: Structure-function correlations. An update and lessons from other integrins
8. Association of the platelet Pl (A) polymorphism of glycoprotein IIb/IIIa and the fibrinogen Bbeta 448 polymorphism with myocardial infarction and extent of coronary artery disease
9. Association of the platelet glycoprotein IIb HPA-3 polymorphism with survival after acute ischemic stroke
10. HPA genotyping by PCR sequence specific priming (PCR-SSP): A streamlined method for rapid routine investigations
11. PlA1/A2 polymorphism of platelet glycoprotein IIIa and risk of acute coronary syndromes in heterozygous familial hypercholesterolemia
12. A2 polymorphism and efficacy of aspirin
13. Coronary thrombosis and the platelet glycoprotein IIIA gene PLA2 polymorphism
14. Increased platelet aggregability associated with platelet GPIIIa PlA2 polymorphism: The Framingham Offspring Study
15. The pathogenesis of coronary artery disease and the acute coronary syndromes
16. Polymorphism of the platelet glycoprotein IIIa gene in patients with coronary stenosis
17. Association of the platelet glycoprotein IIIa PlA1/A2 gene polymorphism to coronary artery disease but not to nonfatal myocardial infarction in low risk patients
18. Polymorphisms of platelet membrane glycoprotein Ib associated with arterial thrombotic disease
19. Increased binding of fibrinogen to glycoprotein IIIa-proline33 (HPA-1b, PlA2, Zwb) positive platelets in patients with cardiovascular disease
20. Polymorphisms of HPA-1 through 6 on platelet membrane glycoprotein receptors are not a genetic risk factor for myocardial infarction in the Japanese population
21. The Leu33/Pro polymorphism (PlA1/PlA2) of the glycoprotein IIIa (GPIIIa) receptor is not related to myocardial infarction in the ECTIM Study. Etude cas-temoins de l'infarctus du myocarde
22. PlA polymorphism of platelet glycoprotein IIIa and risk of restenosis after coronary stent placement
23. Genetic polymorphism of platelet glycoprotein IIIa in patients with acute myocardial infarction and acute ischaemic stroke
24. Nucleotide polymorphisms in the α2 gene define multiple alleles that are associated with differences in platelet α2β1 density
25. The impact of the glycoprotein Ia collagen receptor subunit A1648G gene polymorphism on coronary artery disease and acute myocardial infarction
26. A2 polymorphism
27. A1/A2 polymorphism of glycoprotein IIIa and association with excess procedural risk for coronary catheter interventions: A case-controlled study
28. Probable genetic linkage between genes coding for platelet-specific antigens of the PlA and Bak systems
29. Platelet glycoprotein IIIa polymorphism HPA 1b (PlA2): No association with platelet fibrinogen binding
30. Platelet GP IIIa Pl (A) polymorphisms display different sensitivities to agonists
31. Coronary artery disease and polymorphisms in a receptor mediating shear stress-dependent platelet activation
32. Polymorphisms of human platelet membrane glycoproteins: Structure and clinical significance
33. Array-based multiplex analysis of candidate genes reveals two independent and additive genetic risk factors for myocardial infarction in the Finnish population
34. PlA1/A2 polymorphism of platelet glycoprotein IIIa and risks of myocardial infarction, stroke, and venous thrombosis
35. Glycoprotein IIIa polymorphism and risk of myocardial infarction
36. A point mutation Thr (799) Met on the alpha (2) integrin leads to the formation of new human platelet alloantigen Sit (a) and affects collagen-induced aggregation
37. Lack of relationship between the PlA1/PlA2 polymorphism of platelet glycoprotein IIIa and premature myocardial infarction
38. Inherited platelet glycoprotein polymorphisms and a risk for coronary heart disease in young central Europeans
39. Blood platelet count and function are related to total and cardiovascular death in apparently healthy men
40. Platelet hyperactivity and prognosis in survivors of myocardial infarction
41. 3 enhances outside-in signaling and adhesive functions
42. Platelet glycoprotein IIIa polymorphisms and risk of coronary stent thrombosis
43. A polymorphism of a platelet glycoprotein receptor as an inherited risk factor for coronary thrombosis
44. Laboratory investigation of platelet function: A review of methodology
45. Polymorphism of platelet membrane glycoprotein IIIa: Human platelet antigen 1b (HPA-1b/PlA2) is an inherited risk factor for premature myocardial infarction in coronary artery disease
46. Prospective analysis after coronary-artery bypass grafting: Platelet GP IIIa polymorphism (HPA-1b/PlA2) is a risk factor for bypass occlusion, myocardial infarction, and death